Autoimmune diseases occur when the immune system mistakenly attacks healthy cells. There are over 80 types, including Type 1 ...

Sanofi SNY announced that it signed an agreement with California-based privately held biopharmaceutical company Dren Bio to ...

The deal is the latest in a series of Sanofi investments in its immunology portfolio. According to Sanfoi, DR-0201 can ...

DR-0201, a CD20-directed bispecific antibody, has demonstrated robust B-cell depletion in early clinical studies, showing ...

The deal with startup Dren Bio hands Sanofi a so-called myeloid cell engager that would compete with an array of programs ...

Culton and Myers stressed the importance of raising awareness about these rare diseases and of getting more physicians and ...

Dren Bio is currently evaluating the drug in two ongoing early-stage studies — B-cell non-Hodgkin lymphoma and autoimmune diseases. Sanofi believes that DR-0201 has the potential to reset the ...

In an Instagram post Sunday, Kris shared a few details about her last heartbreak along with her health update.

Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has agreed to acquire DR-0201, a targeted bispecific myeloid ...

A lot of people don’t know that I am an autoimmune hepatitis patient. I have a liver disease, it was diagnosed in 2020,” said ...